Xue Tong-Min, Tao Li-de, Zhang Miao, Zhang Jie, Liu Xia, Chen Guo-Feng, Zhu Yi-Jia, Zhang Pei-Jian
Institute of General Surgical Research, Second Affiliated Hospital, Yangzhou University, Yangzhou, Jiangsu 225002, China.
Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
Dis Markers. 2015;2015:325176. doi: 10.1155/2015/325176. Epub 2015 Nov 3.
miRNA-20b has been shown to be aberrantly expressed in several tumor types. However, the clinical significance of miRNA-20b in the prognosis of patients with hepatocellular carcinoma (HCC) is poorly understood, and the exact role of miRNA-20b in HCC remains unclear. The aim of the present study was to investigate the association of the expression of miR-20b with clinicopathological characteristics and overall survival of HCC patients analyzed by Kaplan-Meier analysis and Cox proportional hazards regression models. Meanwhile, the HIF-1α and VEGF targets of miR-20b have been confirmed. We found not only miR-20b regulation of HIF-1α and VEGF in normal but also regulation of miR-20b in hypoxia. This mechanism would help the tumor cells adapt to the different environments thus promoting the tumor invasion and development. The whole study suggests that miR-20b, HIF-1α, and VEGF serve as a potential therapeutic agent for hepatocellular carcinoma.
已证明miRNA - 20b在多种肿瘤类型中异常表达。然而,miRNA - 20b在肝细胞癌(HCC)患者预后中的临床意义尚不清楚,其在HCC中的确切作用仍不明确。本研究的目的是通过Kaplan - Meier分析和Cox比例风险回归模型,研究miR - 20b表达与HCC患者临床病理特征及总生存期的相关性。同时,已证实miR - 20b的HIF - 1α和VEGF靶点。我们发现,不仅miR - 20b在正常情况下对HIF - 1α和VEGF有调控作用,而且在缺氧条件下对miR - 20b也有调控作用。这种机制有助于肿瘤细胞适应不同环境,从而促进肿瘤侵袭和发展。整个研究表明,miR - 20b、HIF - 1α和VEGF可作为肝细胞癌的潜在治疗药物。